nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—coronary artery disease—type 2 diabetes mellitus	0.129	0.626	CtDrD
Olmesartan—Irbesartan—type 2 diabetes mellitus	0.112	0.389	CrCtD
Olmesartan—Valsartan—type 2 diabetes mellitus	0.0952	0.33	CrCtD
Olmesartan—ABCC2—type 2 diabetes mellitus	0.0839	1	CbGaD
Olmesartan—Losartan—type 2 diabetes mellitus	0.0809	0.281	CrCtD
Olmesartan—hypertension—type 2 diabetes mellitus	0.0768	0.374	CtDrD
Olmesartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0311	0.188	CbGbCtD
Olmesartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.0277	0.167	CbGbCtD
Olmesartan—AGTR1—Losartan—type 2 diabetes mellitus	0.0179	0.108	CbGbCtD
Olmesartan—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0176	0.106	CbGbCtD
Olmesartan—Forasartan—Irbesartan—type 2 diabetes mellitus	0.0149	0.0777	CrCrCtD
Olmesartan—Valsartan—Irbesartan—type 2 diabetes mellitus	0.0149	0.0777	CrCrCtD
Olmesartan—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0143	0.0865	CbGbCtD
Olmesartan—Tasosartan—Irbesartan—type 2 diabetes mellitus	0.0132	0.0687	CrCrCtD
Olmesartan—Forasartan—Valsartan—type 2 diabetes mellitus	0.0127	0.0661	CrCrCtD
Olmesartan—Irbesartan—Valsartan—type 2 diabetes mellitus	0.0127	0.0661	CrCrCtD
Olmesartan—Azilsartan medoxomil—Losartan—type 2 diabetes mellitus	0.0125	0.065	CrCrCtD
Olmesartan—Telmisartan—Losartan—type 2 diabetes mellitus	0.0125	0.065	CrCrCtD
Olmesartan—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0113	0.0683	CbGbCtD
Olmesartan—Tasosartan—Valsartan—type 2 diabetes mellitus	0.0112	0.0584	CrCrCtD
Olmesartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0108	0.0562	CrCrCtD
Olmesartan—Forasartan—Losartan—type 2 diabetes mellitus	0.0108	0.0562	CrCrCtD
Olmesartan—Irbesartan—Losartan—type 2 diabetes mellitus	0.0108	0.0562	CrCrCtD
Olmesartan—Valsartan—Losartan—type 2 diabetes mellitus	0.0108	0.0562	CrCrCtD
Olmesartan—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0102	0.0618	CbGbCtD
Olmesartan—Candesartan—Irbesartan—type 2 diabetes mellitus	0.00991	0.0516	CrCrCtD
Olmesartan—Tasosartan—Losartan—type 2 diabetes mellitus	0.00953	0.0497	CrCrCtD
Olmesartan—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.00945	0.057	CbGbCtD
Olmesartan—Losartan—Valsartan—type 2 diabetes mellitus	0.00916	0.0478	CrCrCtD
Olmesartan—Candesartan—Valsartan—type 2 diabetes mellitus	0.00842	0.0439	CrCrCtD
Olmesartan—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00835	0.0504	CbGbCtD
Olmesartan—SLCO1B3—Losartan—type 2 diabetes mellitus	0.00823	0.0497	CbGbCtD
Olmesartan—Candesartan—Losartan—type 2 diabetes mellitus	0.00716	0.0373	CrCrCtD
Olmesartan—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00479	0.0289	CbGbCtD
Olmesartan—ABCC2—Glyburide—type 2 diabetes mellitus	0.00461	0.0278	CbGbCtD
Olmesartan—Tasosartan—AGTR2—type 2 diabetes mellitus	0.000503	0.448	CrCbGaD
Olmesartan—AGTR1—artery—type 2 diabetes mellitus	0.000401	0.179	CbGeAlD
Olmesartan—AGTR1—endothelium—type 2 diabetes mellitus	0.000339	0.152	CbGeAlD
Olmesartan—Irbesartan—EDNRA—type 2 diabetes mellitus	0.000172	0.153	CrCbGaD
Olmesartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000155	0.0694	CbGeAlD
Olmesartan—SLCO1B3—liver—type 2 diabetes mellitus	0.000142	0.0636	CbGeAlD
Olmesartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000139	0.0623	CbGeAlD
Olmesartan—AGTR1—kidney—type 2 diabetes mellitus	0.000136	0.061	CbGeAlD
Olmesartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000133	0.0594	CbGeAlD
Olmesartan—SLCO1B1—kidney—type 2 diabetes mellitus	0.00013	0.0582	CbGeAlD
Olmesartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000123	0.055	CbGeAlD
Olmesartan—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000112	0.0502	CbGeAlD
Olmesartan—ABCC2—kidney—type 2 diabetes mellitus	9.85e-05	0.0441	CbGeAlD
Olmesartan—ABCC2—cortex of kidney—type 2 diabetes mellitus	9.6e-05	0.0429	CbGeAlD
Olmesartan—Telmisartan—PPARG—type 2 diabetes mellitus	8.94e-05	0.0797	CrCbGaD
Olmesartan—Telmisartan—ABCC2—type 2 diabetes mellitus	8.72e-05	0.0777	CrCbGaD
Olmesartan—AGTR1—liver—type 2 diabetes mellitus	8.62e-05	0.0386	CbGeAlD
Olmesartan—SLCO1B1—liver—type 2 diabetes mellitus	8.21e-05	0.0368	CbGeAlD
Olmesartan—ABCC2—liver—type 2 diabetes mellitus	6.23e-05	0.0279	CbGeAlD
Olmesartan—Tasosartan—CYP3A4—type 2 diabetes mellitus	4.73e-05	0.0421	CrCbGaD
Olmesartan—Irbesartan—CYP1A2—type 2 diabetes mellitus	4.69e-05	0.0418	CrCbGaD
Olmesartan—Losartan—ACE—type 2 diabetes mellitus	4.26e-05	0.038	CrCbGaD
Olmesartan—Valsartan—ALB—type 2 diabetes mellitus	3.58e-05	0.0319	CrCbGaD
Olmesartan—Irbesartan—CYP3A4—type 2 diabetes mellitus	3.11e-05	0.0277	CrCbGaD
Olmesartan—Losartan—CYP1A2—type 2 diabetes mellitus	3.02e-05	0.0269	CrCbGaD
Olmesartan—Losartan—CYP3A4—type 2 diabetes mellitus	2e-05	0.0178	CrCbGaD
Olmesartan—Hypotension—Valsartan—type 2 diabetes mellitus	1.97e-05	0.000417	CcSEcCtD
Olmesartan—Vision blurred—Losartan—type 2 diabetes mellitus	1.97e-05	0.000416	CcSEcCtD
Olmesartan—Vomiting—Sitagliptin—type 2 diabetes mellitus	1.97e-05	0.000415	CcSEcCtD
Olmesartan—Constipation—Gliclazide—type 2 diabetes mellitus	1.97e-05	0.000415	CcSEcCtD
Olmesartan—Pain—Gliclazide—type 2 diabetes mellitus	1.97e-05	0.000415	CcSEcCtD
Olmesartan—Rash—Glimepiride—type 2 diabetes mellitus	1.96e-05	0.000413	CcSEcCtD
Olmesartan—Dermatitis—Glimepiride—type 2 diabetes mellitus	1.96e-05	0.000413	CcSEcCtD
Olmesartan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	1.96e-05	0.000413	CcSEcCtD
Olmesartan—Rash—Sitagliptin—type 2 diabetes mellitus	1.95e-05	0.000412	CcSEcCtD
Olmesartan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	1.95e-05	0.000411	CcSEcCtD
Olmesartan—Headache—Glimepiride—type 2 diabetes mellitus	1.95e-05	0.000411	CcSEcCtD
Olmesartan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	1.94e-05	0.00041	CcSEcCtD
Olmesartan—Cough—Irbesartan—type 2 diabetes mellitus	1.94e-05	0.00041	CcSEcCtD
Olmesartan—Headache—Sitagliptin—type 2 diabetes mellitus	1.94e-05	0.000409	CcSEcCtD
Olmesartan—Anaemia—Losartan—type 2 diabetes mellitus	1.93e-05	0.000408	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	1.92e-05	0.000406	CcSEcCtD
Olmesartan—Agitation—Losartan—type 2 diabetes mellitus	1.92e-05	0.000406	CcSEcCtD
Olmesartan—Oedema—Metformin—type 2 diabetes mellitus	1.92e-05	0.000406	CcSEcCtD
Olmesartan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.92e-05	0.000404	CcSEcCtD
Olmesartan—Angioedema—Losartan—type 2 diabetes mellitus	1.91e-05	0.000404	CcSEcCtD
Olmesartan—Infection—Metformin—type 2 diabetes mellitus	1.91e-05	0.000403	CcSEcCtD
Olmesartan—Insomnia—Valsartan—type 2 diabetes mellitus	1.91e-05	0.000403	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.9e-05	0.000401	CcSEcCtD
Olmesartan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.89e-05	0.0004	CcSEcCtD
Olmesartan—Myalgia—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.0004	CcSEcCtD
Olmesartan—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.0004	CcSEcCtD
Olmesartan—Chest pain—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.0004	CcSEcCtD
Olmesartan—Shock—Metformin—type 2 diabetes mellitus	1.89e-05	0.000399	CcSEcCtD
Olmesartan—Insomnia—Orlistat—type 2 diabetes mellitus	1.89e-05	0.000398	CcSEcCtD
Olmesartan—Malaise—Losartan—type 2 diabetes mellitus	1.89e-05	0.000398	CcSEcCtD
Olmesartan—Anxiety—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.000398	CcSEcCtD
Olmesartan—Nervous system disorder—Metformin—type 2 diabetes mellitus	1.89e-05	0.000398	CcSEcCtD
Olmesartan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.88e-05	0.000398	CcSEcCtD
Olmesartan—Vertigo—Losartan—type 2 diabetes mellitus	1.88e-05	0.000397	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	1.88e-05	0.000397	CcSEcCtD
Olmesartan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.88e-05	0.000397	CcSEcCtD
Olmesartan—Syncope—Losartan—type 2 diabetes mellitus	1.88e-05	0.000396	CcSEcCtD
Olmesartan—Leukopenia—Losartan—type 2 diabetes mellitus	1.87e-05	0.000395	CcSEcCtD
Olmesartan—Discomfort—Irbesartan—type 2 diabetes mellitus	1.87e-05	0.000395	CcSEcCtD
Olmesartan—Skin disorder—Metformin—type 2 diabetes mellitus	1.87e-05	0.000394	CcSEcCtD
Olmesartan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.86e-05	0.000392	CcSEcCtD
Olmesartan—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.86e-05	0.000392	CcSEcCtD
Olmesartan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	1.86e-05	0.000392	CcSEcCtD
Olmesartan—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.85e-05	0.000391	CcSEcCtD
Olmesartan—Palpitations—Losartan—type 2 diabetes mellitus	1.85e-05	0.00039	CcSEcCtD
Olmesartan—Nausea—Glimepiride—type 2 diabetes mellitus	1.84e-05	0.000389	CcSEcCtD
Olmesartan—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.84e-05	0.000389	CcSEcCtD
Olmesartan—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.84e-05	0.000388	CcSEcCtD
Olmesartan—Nausea—Sitagliptin—type 2 diabetes mellitus	1.84e-05	0.000388	CcSEcCtD
Olmesartan—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.84e-05	0.000388	CcSEcCtD
Olmesartan—Asthenia—Glyburide—type 2 diabetes mellitus	1.84e-05	0.000388	CcSEcCtD
Olmesartan—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.84e-05	0.000388	CcSEcCtD
Olmesartan—Anorexia—Metformin—type 2 diabetes mellitus	1.83e-05	0.000387	CcSEcCtD
Olmesartan—Cough—Losartan—type 2 diabetes mellitus	1.83e-05	0.000386	CcSEcCtD
Olmesartan—Urticaria—Gliclazide—type 2 diabetes mellitus	1.83e-05	0.000386	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.82e-05	0.000385	CcSEcCtD
Olmesartan—Alopecia—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000385	CcSEcCtD
Olmesartan—Fatigue—Valsartan—type 2 diabetes mellitus	1.82e-05	0.000384	CcSEcCtD
Olmesartan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.82e-05	0.000384	CcSEcCtD
Olmesartan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.82e-05	0.000384	CcSEcCtD
Olmesartan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000383	CcSEcCtD
Olmesartan—Oedema—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000383	CcSEcCtD
Olmesartan—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.81e-05	0.000383	CcSEcCtD
Olmesartan—Pruritus—Glyburide—type 2 diabetes mellitus	1.81e-05	0.000382	CcSEcCtD
Olmesartan—Mental disorder—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000381	CcSEcCtD
Olmesartan—Constipation—Valsartan—type 2 diabetes mellitus	1.81e-05	0.000381	CcSEcCtD
Olmesartan—Infection—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000381	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.8e-05	0.00038	CcSEcCtD
Olmesartan—Fatigue—Orlistat—type 2 diabetes mellitus	1.8e-05	0.00038	CcSEcCtD
Olmesartan—Hypotension—Metformin—type 2 diabetes mellitus	1.8e-05	0.000379	CcSEcCtD
Olmesartan—Malnutrition—Ramipril—type 2 diabetes mellitus	1.79e-05	0.000379	CcSEcCtD
Olmesartan—Shock—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000377	CcSEcCtD
Olmesartan—Pain—Orlistat—type 2 diabetes mellitus	1.79e-05	0.000377	CcSEcCtD
Olmesartan—Arthralgia—Losartan—type 2 diabetes mellitus	1.78e-05	0.000376	CcSEcCtD
Olmesartan—Chest pain—Losartan—type 2 diabetes mellitus	1.78e-05	0.000376	CcSEcCtD
Olmesartan—Myalgia—Losartan—type 2 diabetes mellitus	1.78e-05	0.000376	CcSEcCtD
Olmesartan—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.78e-05	0.000376	CcSEcCtD
Olmesartan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	1.78e-05	0.000376	CcSEcCtD
Olmesartan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.78e-05	0.000375	CcSEcCtD
Olmesartan—Anxiety—Losartan—type 2 diabetes mellitus	1.78e-05	0.000375	CcSEcCtD
Olmesartan—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.77e-05	0.000374	CcSEcCtD
Olmesartan—Rash—Bromocriptine—type 2 diabetes mellitus	1.77e-05	0.000373	CcSEcCtD
Olmesartan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.76e-05	0.000372	CcSEcCtD
Olmesartan—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.000372	CcSEcCtD
Olmesartan—Discomfort—Losartan—type 2 diabetes mellitus	1.76e-05	0.000372	CcSEcCtD
Olmesartan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.00037	CcSEcCtD
Olmesartan—Headache—Bromocriptine—type 2 diabetes mellitus	1.75e-05	0.00037	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.75e-05	0.00037	CcSEcCtD
Olmesartan—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.75e-05	0.00037	CcSEcCtD
Olmesartan—Losartan—ALB—type 2 diabetes mellitus	1.75e-05	0.0156	CrCbGaD
Olmesartan—Anorexia—Irbesartan—type 2 diabetes mellitus	1.73e-05	0.000365	CcSEcCtD
Olmesartan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.73e-05	0.000365	CcSEcCtD
Olmesartan—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.73e-05	0.000364	CcSEcCtD
Olmesartan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000363	CcSEcCtD
Olmesartan—Oedema—Losartan—type 2 diabetes mellitus	1.71e-05	0.000361	CcSEcCtD
Olmesartan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	1.71e-05	0.000361	CcSEcCtD
Olmesartan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.71e-05	0.00036	CcSEcCtD
Olmesartan—Infection—Losartan—type 2 diabetes mellitus	1.7e-05	0.000358	CcSEcCtD
Olmesartan—Hypotension—Irbesartan—type 2 diabetes mellitus	1.7e-05	0.000358	CcSEcCtD
Olmesartan—Dyspepsia—Metformin—type 2 diabetes mellitus	1.69e-05	0.000357	CcSEcCtD
Olmesartan—Shock—Losartan—type 2 diabetes mellitus	1.68e-05	0.000355	CcSEcCtD
Olmesartan—Urticaria—Valsartan—type 2 diabetes mellitus	1.68e-05	0.000354	CcSEcCtD
Olmesartan—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.68e-05	0.000354	CcSEcCtD
Olmesartan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.67e-05	0.000353	CcSEcCtD
Olmesartan—Decreased appetite—Metformin—type 2 diabetes mellitus	1.67e-05	0.000353	CcSEcCtD
Olmesartan—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.67e-05	0.000352	CcSEcCtD
Olmesartan—Tachycardia—Losartan—type 2 diabetes mellitus	1.67e-05	0.000352	CcSEcCtD
Olmesartan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000352	CcSEcCtD
Olmesartan—Nausea—Bromocriptine—type 2 diabetes mellitus	1.66e-05	0.000351	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.66e-05	0.000351	CcSEcCtD
Olmesartan—Fatigue—Metformin—type 2 diabetes mellitus	1.66e-05	0.00035	CcSEcCtD
Olmesartan—Urticaria—Orlistat—type 2 diabetes mellitus	1.66e-05	0.00035	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000349	CcSEcCtD
Olmesartan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.65e-05	0.000349	CcSEcCtD
Olmesartan—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.65e-05	0.000348	CcSEcCtD
Olmesartan—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.65e-05	0.000348	CcSEcCtD
Olmesartan—Asthenia—Gliclazide—type 2 diabetes mellitus	1.65e-05	0.000348	CcSEcCtD
Olmesartan—Agitation—Ramipril—type 2 diabetes mellitus	1.65e-05	0.000348	CcSEcCtD
Olmesartan—Constipation—Metformin—type 2 diabetes mellitus	1.65e-05	0.000347	CcSEcCtD
Olmesartan—Angioedema—Ramipril—type 2 diabetes mellitus	1.64e-05	0.000346	CcSEcCtD
Olmesartan—Anorexia—Losartan—type 2 diabetes mellitus	1.63e-05	0.000344	CcSEcCtD
Olmesartan—Vomiting—Glyburide—type 2 diabetes mellitus	1.63e-05	0.000344	CcSEcCtD
Olmesartan—Pruritus—Gliclazide—type 2 diabetes mellitus	1.63e-05	0.000343	CcSEcCtD
Olmesartan—Malaise—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000342	CcSEcCtD
Olmesartan—Rash—Glyburide—type 2 diabetes mellitus	1.61e-05	0.000341	CcSEcCtD
Olmesartan—Dermatitis—Glyburide—type 2 diabetes mellitus	1.61e-05	0.00034	CcSEcCtD
Olmesartan—Vertigo—Ramipril—type 2 diabetes mellitus	1.61e-05	0.00034	CcSEcCtD
Olmesartan—Syncope—Ramipril—type 2 diabetes mellitus	1.61e-05	0.00034	CcSEcCtD
Olmesartan—Leukopenia—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000339	CcSEcCtD
Olmesartan—Headache—Glyburide—type 2 diabetes mellitus	1.6e-05	0.000339	CcSEcCtD
Olmesartan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000337	CcSEcCtD
Olmesartan—Hypotension—Losartan—type 2 diabetes mellitus	1.6e-05	0.000337	CcSEcCtD
Olmesartan—Palpitations—Ramipril—type 2 diabetes mellitus	1.59e-05	0.000335	CcSEcCtD
Olmesartan—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.59e-05	0.000335	CcSEcCtD
Olmesartan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.000333	CcSEcCtD
Olmesartan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000333	CcSEcCtD
Olmesartan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.57e-05	0.000332	CcSEcCtD
Olmesartan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.57e-05	0.000332	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000331	CcSEcCtD
Olmesartan—Cough—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000331	CcSEcCtD
Olmesartan—Fatigue—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.00033	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.56e-05	0.000329	CcSEcCtD
Olmesartan—Constipation—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.000328	CcSEcCtD
Olmesartan—Pain—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.000328	CcSEcCtD
Olmesartan—Insomnia—Losartan—type 2 diabetes mellitus	1.55e-05	0.000326	CcSEcCtD
Olmesartan—Urticaria—Metformin—type 2 diabetes mellitus	1.53e-05	0.000323	CcSEcCtD
Olmesartan—Chest pain—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000323	CcSEcCtD
Olmesartan—Myalgia—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000323	CcSEcCtD
Olmesartan—Arthralgia—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000323	CcSEcCtD
Olmesartan—Anxiety—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000321	CcSEcCtD
Olmesartan—Nausea—Glyburide—type 2 diabetes mellitus	1.52e-05	0.000321	CcSEcCtD
Olmesartan—Abdominal pain—Metformin—type 2 diabetes mellitus	1.52e-05	0.000321	CcSEcCtD
Olmesartan—Dizziness—Gliclazide—type 2 diabetes mellitus	1.52e-05	0.000321	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.52e-05	0.00032	CcSEcCtD
Olmesartan—Asthenia—Valsartan—type 2 diabetes mellitus	1.52e-05	0.00032	CcSEcCtD
Olmesartan—Discomfort—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000319	CcSEcCtD
Olmesartan—Dyspepsia—Losartan—type 2 diabetes mellitus	1.5e-05	0.000317	CcSEcCtD
Olmesartan—Asthenia—Orlistat—type 2 diabetes mellitus	1.5e-05	0.000316	CcSEcCtD
Olmesartan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000316	CcSEcCtD
Olmesartan—Pruritus—Valsartan—type 2 diabetes mellitus	1.49e-05	0.000315	CcSEcCtD
Olmesartan—Decreased appetite—Losartan—type 2 diabetes mellitus	1.49e-05	0.000313	CcSEcCtD
Olmesartan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.48e-05	0.000313	CcSEcCtD
Olmesartan—Pruritus—Orlistat—type 2 diabetes mellitus	1.48e-05	0.000312	CcSEcCtD
Olmesartan—Fatigue—Losartan—type 2 diabetes mellitus	1.47e-05	0.000311	CcSEcCtD
Olmesartan—Oedema—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000309	CcSEcCtD
Olmesartan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000309	CcSEcCtD
Olmesartan—Vomiting—Gliclazide—type 2 diabetes mellitus	1.46e-05	0.000309	CcSEcCtD
Olmesartan—Constipation—Losartan—type 2 diabetes mellitus	1.46e-05	0.000308	CcSEcCtD
Olmesartan—Pain—Losartan—type 2 diabetes mellitus	1.46e-05	0.000308	CcSEcCtD
Olmesartan—Rash—Gliclazide—type 2 diabetes mellitus	1.45e-05	0.000306	CcSEcCtD
Olmesartan—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.45e-05	0.000306	CcSEcCtD
Olmesartan—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.45e-05	0.000305	CcSEcCtD
Olmesartan—Urticaria—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000304	CcSEcCtD
Olmesartan—Shock—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000304	CcSEcCtD
Olmesartan—Headache—Gliclazide—type 2 diabetes mellitus	1.44e-05	0.000304	CcSEcCtD
Olmesartan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000303	CcSEcCtD
Olmesartan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000303	CcSEcCtD
Olmesartan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000303	CcSEcCtD
Olmesartan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000303	CcSEcCtD
Olmesartan—Tachycardia—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000302	CcSEcCtD
Olmesartan—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.43e-05	0.000301	CcSEcCtD
Olmesartan—Skin disorder—Ramipril—type 2 diabetes mellitus	1.42e-05	0.0003	CcSEcCtD
Olmesartan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000299	CcSEcCtD
Olmesartan—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.41e-05	0.000297	CcSEcCtD
Olmesartan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.4e-05	0.000295	CcSEcCtD
Olmesartan—Dizziness—Valsartan—type 2 diabetes mellitus	1.4e-05	0.000295	CcSEcCtD
Olmesartan—Anorexia—Ramipril—type 2 diabetes mellitus	1.4e-05	0.000295	CcSEcCtD
Olmesartan—Dizziness—Orlistat—type 2 diabetes mellitus	1.38e-05	0.000291	CcSEcCtD
Olmesartan—Asthenia—Metformin—type 2 diabetes mellitus	1.38e-05	0.000291	CcSEcCtD
Olmesartan—Hypotension—Ramipril—type 2 diabetes mellitus	1.37e-05	0.000289	CcSEcCtD
Olmesartan—Nausea—Gliclazide—type 2 diabetes mellitus	1.37e-05	0.000288	CcSEcCtD
Olmesartan—Pruritus—Metformin—type 2 diabetes mellitus	1.36e-05	0.000287	CcSEcCtD
Olmesartan—Urticaria—Losartan—type 2 diabetes mellitus	1.36e-05	0.000286	CcSEcCtD
Olmesartan—Body temperature increased—Losartan—type 2 diabetes mellitus	1.35e-05	0.000285	CcSEcCtD
Olmesartan—Abdominal pain—Losartan—type 2 diabetes mellitus	1.35e-05	0.000285	CcSEcCtD
Olmesartan—Vomiting—Valsartan—type 2 diabetes mellitus	1.34e-05	0.000283	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000282	CcSEcCtD
Olmesartan—Rash—Valsartan—type 2 diabetes mellitus	1.33e-05	0.000281	CcSEcCtD
Olmesartan—Dermatitis—Valsartan—type 2 diabetes mellitus	1.33e-05	0.000281	CcSEcCtD
Olmesartan—Vomiting—Orlistat—type 2 diabetes mellitus	1.33e-05	0.00028	CcSEcCtD
Olmesartan—Insomnia—Ramipril—type 2 diabetes mellitus	1.32e-05	0.00028	CcSEcCtD
Olmesartan—Headache—Valsartan—type 2 diabetes mellitus	1.32e-05	0.000279	CcSEcCtD
Olmesartan—Diarrhoea—Metformin—type 2 diabetes mellitus	1.32e-05	0.000278	CcSEcCtD
Olmesartan—Rash—Orlistat—type 2 diabetes mellitus	1.32e-05	0.000278	CcSEcCtD
Olmesartan—Dermatitis—Orlistat—type 2 diabetes mellitus	1.31e-05	0.000278	CcSEcCtD
Olmesartan—Headache—Orlistat—type 2 diabetes mellitus	1.31e-05	0.000276	CcSEcCtD
Olmesartan—Asthenia—Irbesartan—type 2 diabetes mellitus	1.3e-05	0.000275	CcSEcCtD
Olmesartan—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.29e-05	0.000272	CcSEcCtD
Olmesartan—Pruritus—Irbesartan—type 2 diabetes mellitus	1.28e-05	0.000271	CcSEcCtD
Olmesartan—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000269	CcSEcCtD
Olmesartan—Dizziness—Metformin—type 2 diabetes mellitus	1.27e-05	0.000268	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000267	CcSEcCtD
Olmesartan—Fatigue—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000267	CcSEcCtD
Olmesartan—Nausea—Valsartan—type 2 diabetes mellitus	1.25e-05	0.000265	CcSEcCtD
Olmesartan—Constipation—Ramipril—type 2 diabetes mellitus	1.25e-05	0.000264	CcSEcCtD
Olmesartan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.24e-05	0.000262	CcSEcCtD
Olmesartan—Nausea—Orlistat—type 2 diabetes mellitus	1.24e-05	0.000262	CcSEcCtD
Olmesartan—Asthenia—Losartan—type 2 diabetes mellitus	1.23e-05	0.000259	CcSEcCtD
Olmesartan—Vomiting—Metformin—type 2 diabetes mellitus	1.22e-05	0.000258	CcSEcCtD
Olmesartan—Rash—Metformin—type 2 diabetes mellitus	1.21e-05	0.000256	CcSEcCtD
Olmesartan—Dermatitis—Metformin—type 2 diabetes mellitus	1.21e-05	0.000256	CcSEcCtD
Olmesartan—Pruritus—Losartan—type 2 diabetes mellitus	1.21e-05	0.000255	CcSEcCtD
Olmesartan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000255	CcSEcCtD
Olmesartan—Headache—Metformin—type 2 diabetes mellitus	1.21e-05	0.000254	CcSEcCtD
Olmesartan—Dizziness—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.000253	CcSEcCtD
Olmesartan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.2e-05	0.000253	CcSEcCtD
Olmesartan—Diarrhoea—Losartan—type 2 diabetes mellitus	1.17e-05	0.000247	CcSEcCtD
Olmesartan—Urticaria—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000246	CcSEcCtD
Olmesartan—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000244	CcSEcCtD
Olmesartan—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000244	CcSEcCtD
Olmesartan—Vomiting—Irbesartan—type 2 diabetes mellitus	1.15e-05	0.000244	CcSEcCtD
Olmesartan—Rash—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.000242	CcSEcCtD
Olmesartan—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.000241	CcSEcCtD
Olmesartan—Nausea—Metformin—type 2 diabetes mellitus	1.14e-05	0.000241	CcSEcCtD
Olmesartan—Headache—Irbesartan—type 2 diabetes mellitus	1.14e-05	0.00024	CcSEcCtD
Olmesartan—Dizziness—Losartan—type 2 diabetes mellitus	1.13e-05	0.000238	CcSEcCtD
Olmesartan—Vomiting—Losartan—type 2 diabetes mellitus	1.09e-05	0.000229	CcSEcCtD
Olmesartan—Nausea—Irbesartan—type 2 diabetes mellitus	1.08e-05	0.000228	CcSEcCtD
Olmesartan—Rash—Losartan—type 2 diabetes mellitus	1.08e-05	0.000227	CcSEcCtD
Olmesartan—Dermatitis—Losartan—type 2 diabetes mellitus	1.08e-05	0.000227	CcSEcCtD
Olmesartan—Headache—Losartan—type 2 diabetes mellitus	1.07e-05	0.000226	CcSEcCtD
Olmesartan—Asthenia—Ramipril—type 2 diabetes mellitus	1.05e-05	0.000222	CcSEcCtD
Olmesartan—Pruritus—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000219	CcSEcCtD
Olmesartan—Nausea—Losartan—type 2 diabetes mellitus	1.01e-05	0.000214	CcSEcCtD
Olmesartan—Diarrhoea—Ramipril—type 2 diabetes mellitus	1e-05	0.000212	CcSEcCtD
Olmesartan—Dizziness—Ramipril—type 2 diabetes mellitus	9.69e-06	0.000204	CcSEcCtD
Olmesartan—Vomiting—Ramipril—type 2 diabetes mellitus	9.31e-06	0.000197	CcSEcCtD
Olmesartan—Rash—Ramipril—type 2 diabetes mellitus	9.24e-06	0.000195	CcSEcCtD
Olmesartan—Dermatitis—Ramipril—type 2 diabetes mellitus	9.23e-06	0.000195	CcSEcCtD
Olmesartan—Headache—Ramipril—type 2 diabetes mellitus	9.18e-06	0.000194	CcSEcCtD
Olmesartan—Nausea—Ramipril—type 2 diabetes mellitus	8.7e-06	0.000184	CcSEcCtD
Olmesartan—AGTR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.76e-06	0.000547	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.7e-06	0.000542	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.66e-06	0.000539	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.6e-06	0.000535	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SRD5A1—type 2 diabetes mellitus	7.58e-06	0.000534	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.54e-06	0.000531	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.46e-06	0.000526	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.44e-06	0.000525	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.36e-06	0.000519	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	7.33e-06	0.000516	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.28e-06	0.000513	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GLP1R—type 2 diabetes mellitus	7.27e-06	0.000512	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ACACA—type 2 diabetes mellitus	7.23e-06	0.00051	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—STAR—type 2 diabetes mellitus	7.23e-06	0.00051	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD17B3—type 2 diabetes mellitus	7.23e-06	0.00051	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	7.23e-06	0.000509	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.22e-06	0.000508	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.15e-06	0.000504	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.15e-06	0.000504	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.05e-06	0.000497	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7e-06	0.000493	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.97e-06	0.000491	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.97e-06	0.000491	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.95e-06	0.00049	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.95e-06	0.00049	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.94e-06	0.000489	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CBS—type 2 diabetes mellitus	6.93e-06	0.000489	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCC8—type 2 diabetes mellitus	6.93e-06	0.000489	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.92e-06	0.000487	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.86e-06	0.000483	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A2—type 2 diabetes mellitus	6.79e-06	0.000478	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—COX2—type 2 diabetes mellitus	6.68e-06	0.00047	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A2—type 2 diabetes mellitus	6.68e-06	0.00047	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CPT1A—type 2 diabetes mellitus	6.65e-06	0.000469	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTR—type 2 diabetes mellitus	6.65e-06	0.000469	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.64e-06	0.000468	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.61e-06	0.000466	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.61e-06	0.000465	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOA6—type 2 diabetes mellitus	6.56e-06	0.000462	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.55e-06	0.000462	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.55e-06	0.000461	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NAMPT—type 2 diabetes mellitus	6.52e-06	0.00046	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.51e-06	0.000459	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.48e-06	0.000457	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HBA1—type 2 diabetes mellitus	6.48e-06	0.000457	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LIPC—type 2 diabetes mellitus	6.48e-06	0.000457	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCK—type 2 diabetes mellitus	6.48e-06	0.000457	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD11B1—type 2 diabetes mellitus	6.45e-06	0.000454	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UCP3—type 2 diabetes mellitus	6.45e-06	0.000454	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UCP2—type 2 diabetes mellitus	6.45e-06	0.000454	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP11A1—type 2 diabetes mellitus	6.44e-06	0.000454	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.36e-06	0.000448	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.33e-06	0.000446	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC9A1—type 2 diabetes mellitus	6.33e-06	0.000446	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.28e-06	0.000443	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CETP—type 2 diabetes mellitus	6.25e-06	0.000441	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.25e-06	0.00044	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.23e-06	0.000439	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.21e-06	0.000438	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.2e-06	0.000437	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.17e-06	0.000435	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.15e-06	0.000433	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INSR—type 2 diabetes mellitus	6.14e-06	0.000432	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PCK1—type 2 diabetes mellitus	6.06e-06	0.000427	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.04e-06	0.000426	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.03e-06	0.000425	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.02e-06	0.000424	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.99e-06	0.000422	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.97e-06	0.00042	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.94e-06	0.000419	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.91e-06	0.000417	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.91e-06	0.000417	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.83e-06	0.000411	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.82e-06	0.00041	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PSMD6—type 2 diabetes mellitus	5.81e-06	0.00041	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SNAP25—type 2 diabetes mellitus	5.81e-06	0.00041	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SREBF1—type 2 diabetes mellitus	5.81e-06	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.78e-06	0.000407	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.74e-06	0.000404	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CTGF—type 2 diabetes mellitus	5.71e-06	0.000402	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HK1—type 2 diabetes mellitus	5.68e-06	0.0004	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.67e-06	0.000399	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMGCR—type 2 diabetes mellitus	5.66e-06	0.000398	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.59e-06	0.000394	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.58e-06	0.000393	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.57e-06	0.000393	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.57e-06	0.000393	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.55e-06	0.000391	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.54e-06	0.000391	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADRA2A—type 2 diabetes mellitus	5.53e-06	0.00039	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.49e-06	0.000387	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HSD3B2—type 2 diabetes mellitus	5.48e-06	0.000386	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPA—type 2 diabetes mellitus	5.48e-06	0.000386	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—KCNJ11—type 2 diabetes mellitus	5.48e-06	0.000386	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCKR—type 2 diabetes mellitus	5.48e-06	0.000386	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.42e-06	0.000382	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.4e-06	0.00038	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.4e-06	0.00038	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.34e-06	0.000376	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2E1—type 2 diabetes mellitus	5.32e-06	0.000375	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.3e-06	0.000374	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.28e-06	0.000372	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.28e-06	0.000372	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.27e-06	0.000371	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1A2—type 2 diabetes mellitus	5.26e-06	0.00037	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A1—type 2 diabetes mellitus	5.26e-06	0.00037	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALDOB—type 2 diabetes mellitus	5.26e-06	0.00037	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.22e-06	0.000368	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP3A4—type 2 diabetes mellitus	5.13e-06	0.000361	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.1e-06	0.00036	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.1e-06	0.000359	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.07e-06	0.000357	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GCG—type 2 diabetes mellitus	5.04e-06	0.000355	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC2A4—type 2 diabetes mellitus	5.04e-06	0.000355	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.01e-06	0.000353	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.01e-06	0.000353	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5e-06	0.000352	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.94e-06	0.000348	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.91e-06	0.000346	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.89e-06	0.000345	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GLP1R—type 2 diabetes mellitus	4.89e-06	0.000344	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.83e-06	0.00034	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.83e-06	0.00034	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.75e-06	0.000335	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.74e-06	0.000334	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.7e-06	0.000331	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.56e-06	0.000321	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.52e-06	0.000319	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTR—type 2 diabetes mellitus	4.47e-06	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CPT1A—type 2 diabetes mellitus	4.47e-06	0.000315	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.44e-06	0.000313	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.44e-06	0.000313	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NAMPT—type 2 diabetes mellitus	4.38e-06	0.000309	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.36e-06	0.000307	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LIPC—type 2 diabetes mellitus	4.35e-06	0.000307	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HBA1—type 2 diabetes mellitus	4.35e-06	0.000307	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCK—type 2 diabetes mellitus	4.35e-06	0.000307	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.34e-06	0.000306	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNB3—type 2 diabetes mellitus	4.34e-06	0.000306	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.33e-06	0.000305	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HMOX1—type 2 diabetes mellitus	4.32e-06	0.000305	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—type 2 diabetes mellitus	4.27e-06	0.000301	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.25e-06	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.2e-06	0.000296	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CETP—type 2 diabetes mellitus	4.2e-06	0.000296	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.16e-06	0.000293	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOB—type 2 diabetes mellitus	4.14e-06	0.000292	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.11e-06	0.000289	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.11e-06	0.000289	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.09e-06	0.000288	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.07e-06	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTM1—type 2 diabetes mellitus	4.03e-06	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.03e-06	0.000284	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.97e-06	0.00028	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.97e-06	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LPL—type 2 diabetes mellitus	3.96e-06	0.000279	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.95e-06	0.000279	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.92e-06	0.000276	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.91e-06	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PSMD6—type 2 diabetes mellitus	3.91e-06	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SREBF1—type 2 diabetes mellitus	3.91e-06	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SNAP25—type 2 diabetes mellitus	3.91e-06	0.000275	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ADCY5—type 2 diabetes mellitus	3.87e-06	0.000273	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPX1—type 2 diabetes mellitus	3.86e-06	0.000272	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CTGF—type 2 diabetes mellitus	3.83e-06	0.00027	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMGCR—type 2 diabetes mellitus	3.8e-06	0.000268	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.79e-06	0.000267	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD36—type 2 diabetes mellitus	3.76e-06	0.000265	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.75e-06	0.000264	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.72e-06	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.72e-06	0.000262	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPP2CA—type 2 diabetes mellitus	3.71e-06	0.000261	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.71e-06	0.000261	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.57e-06	0.000252	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTHFR—type 2 diabetes mellitus	3.56e-06	0.000251	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.56e-06	0.000251	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.53e-06	0.000249	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.53e-06	0.000249	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARA—type 2 diabetes mellitus	3.49e-06	0.000246	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.49e-06	0.000246	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.44e-06	0.000243	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.43e-06	0.000241	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	3.41e-06	0.00024	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.39e-06	0.000239	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GCG—type 2 diabetes mellitus	3.39e-06	0.000239	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AGT—type 2 diabetes mellitus	3.38e-06	0.000238	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CALM1—type 2 diabetes mellitus	3.33e-06	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOE—type 2 diabetes mellitus	3.32e-06	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—APOA1—type 2 diabetes mellitus	3.28e-06	0.000231	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.25e-06	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.25e-06	0.000229	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.24e-06	0.000228	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.19e-06	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.18e-06	0.000224	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.18e-06	0.000224	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.14e-06	0.000221	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3e-06	0.000211	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.92e-06	0.000206	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	2.92e-06	0.000206	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	2.91e-06	0.000205	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—type 2 diabetes mellitus	2.89e-06	0.000203	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	2.87e-06	0.000202	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.83e-06	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—INS—type 2 diabetes mellitus	2.83e-06	0.0002	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	2.78e-06	0.000196	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	2.71e-06	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	2.71e-06	0.000191	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.67e-06	0.000188	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	2.66e-06	0.000187	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.63e-06	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.62e-06	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.61e-06	0.000184	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	2.6e-06	0.000183	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—type 2 diabetes mellitus	2.6e-06	0.000183	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	2.59e-06	0.000183	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	2.52e-06	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.49e-06	0.000176	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.49e-06	0.000176	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-06	0.000175	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-06	0.000175	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	2.39e-06	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.38e-06	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.38e-06	0.000168	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	2.35e-06	0.000165	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	2.27e-06	0.00016	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-06	0.00016	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.24e-06	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.24e-06	0.000158	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	2.23e-06	0.000157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.2e-06	0.000155	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.04e-06	0.000144	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.02e-06	0.000142	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.01e-06	0.000141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.94e-06	0.000137	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.91e-06	0.000135	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	0.000134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.89e-06	0.000133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.85e-06	0.000131	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.76e-06	0.000124	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.74e-06	0.000123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.71e-06	0.000121	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.67e-06	0.000118	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.67e-06	0.000118	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.57e-06	0.000111	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.54e-06	0.000109	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	0.000108	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	8.36e-05	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-06	8.04e-05	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	7.71e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	7.67e-07	5.41e-05	CbGpPWpGaD
